{"url_path":"/sec/mgnx/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1125345/0001125345-26-000038-index.html","accession_number":"0001125345-26-000038","cik":"0001125345","ticker":"MGNX","issuer_name":"MACROGENICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1125345/0001125345-26-000038-index.html","primary_entity_key":"0001125345","primary_entity_name":"MACROGENICS INC"},"word_count":105,"has_tables":true,"body_markdown":"Item 1.\n\nLegal Proceedings\n\nIn the ordinary course of business, we are or may be involved in various legal or regulatory proceedings, claims or class actions related to alleged patent infringements and other intellectual property rights, or alleged violation of commercial, corporate, securities, labor and employment, and other matters incidental to our business. We do not currently, however, expect such legal proceedings to have a material adverse effect on our business, financial condition or results of operations. However, depending on the nature and timing of a given dispute, an eventual unfavorable resolution could materially affect our current or future results of operations or cash flows."}